Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-21

Clinical Trial Update: Depression and Dopamine Transporter Function Study Using C-11 Altropane

View source ↗

Summary

A completed clinical trial studied dopamine transporter function in major depressive disorder and anhedonia using the PET tracer C-11 Altropane.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • C-11 Altropane (Altropane)

Snippet

Sponsor: Mclean Hospital | Conditions: Major Depressive Disorder, Anhedonia | Status: COMPLETED